BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22973485)

  • 1. National Cholesterol Education Program Adult Treatment Panel III Versus International Diabetic Federation Definition of Metabolic Syndrome, Which One is Associated with Diabetes Mellitus and Coronary Artery Disease?
    Rezaianzadeh A; Namayandeh SM; Sadr SM
    Int J Prev Med; 2012 Aug; 3(8):552-8. PubMed ID: 22973485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
    Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS
    Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population.
    Choi KM; Kim SM; Kim YE; Choi DS; Baik SH; Lee J;
    Metabolism; 2007 Apr; 56(4):552-8. PubMed ID: 17379016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reliability of the National Cholesterol Education Program's Adult Treatment Panel III (NCEP/ATP III) and the International Diabetes Federation (IDF) definitions in diagnosing metabolic syndrome (MetS) among Gaza Strip Palestinians.
    Sirdah MM; Abu Ghali AS; Al Laham NA
    Diabetes Metab Syndr; 2012; 6(1):4-8. PubMed ID: 23014247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Metabolic Syndrome among Malaysians using the International Diabetes Federation, National Cholesterol Education Program and Modified World Health Organization Definitions.
    Bee YT; Haresh KK; Rajibans S
    Malays J Nutr; 2008 Mar; 14(1):65-77. PubMed ID: 22691765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of metabolic syndrome and consistency in its diagnosis in type 2 diabetic patients in Spain].
    Rodríguez Bernardino A; García Polavieja P; Reviriego Fernández J; Serrano Ríos M
    Endocrinol Nutr; 2010 Feb; 57(2):60-70. PubMed ID: 20153706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study.
    Bener A; Zirie M; Musallam M; Khader YS; Al-Hamaq AO
    Metab Syndr Relat Disord; 2009 Jun; 7(3):221-9. PubMed ID: 19320557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the association of two metabolic syndrome definitions, NCEP ATP III and IDF, with the risk of developing atherosclerotic cardiovascular disease: An analytical cross-sectional study.
    Yousefzadeh G; Sayyadi A; Najafipour H; Sabaghnejad V; Pezeshki S
    Endocrinol Diabetes Metab; 2024 Jan; 7(1):e468. PubMed ID: 38268305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
    Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
    Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Metabolic Syndrome and Diabetes Mellitus According to International Diabetic Federation and National Cholesterol Education Program Adult Treatment Panel III Criteria: a Cross-sectional Study.
    James M; Varghese TP; Sharma R; Chand S
    J Diabetes Metab Disord; 2020 Jun; 19(1):437-443. PubMed ID: 32550195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of vascular disease in metabolic syndrome using three proposed definitions.
    Athyros VG; Ganotakis ES; Elisaf MS; Liberopoulos EN; Goudevenos IA; Karagiannis A;
    Int J Cardiol; 2007 Apr; 117(2):204-10. PubMed ID: 16854482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of the International Diabetes Federation definition of metabolic syndrome in Chinese patients older than 30 years and diagnosed with type 2 diabetes mellitus.
    Lu B; Yang Y; Song X; Dong X; Zhang Z; Zhou L; Li Y; Zhao N; Zhu X; Hu R
    Metabolism; 2006 Aug; 55(8):1088-96. PubMed ID: 16839846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
    de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
    Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The implications of anthropometric, inflammatory and glycaemic control indices in the epidemiology of the metabolic syndrome given by different definitions: a classification analysis.
    Panagiotakos DB; Pitsavos C; Das UN; Skoumas Y; Stefanadis C
    Diabetes Obes Metab; 2007 Sep; 9(5):660-8. PubMed ID: 17697058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease.
    Luk AO; Ma RC; So WY; Yang XL; Kong AP; Ozaki R; Ko GT; Chow CC; Cockram CS; Chan JC; Tong PC
    Diabet Med; 2008 Dec; 25(12):1419-25. PubMed ID: 19046240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome in the Philippine general population: prevalence and risk for atherosclerotic cardiovascular disease and diabetes mellitus.
    Morales DD; Punzalan FE; Paz-Pacheco E; Sy RG; Duante CA;
    Diab Vasc Dis Res; 2008 Mar; 5(1):36-43. PubMed ID: 18398811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the prevalence of metabolic syndrome and its association with diabetes and cardiovascular disease in the rural population of Bangladesh using the modified National Cholesterol Education Program Expert Panel Adult Treatment Panel III and International Diabetes Federation definitions.
    Bhowmik B; Afsana F; Siddiquee T; Munir SB; Sheikh F; Wright E; Bhuiyan FR; Ashrafuzzaman SM; Mahtab H; Azad Khan AK; Hussain A
    J Diabetes Investig; 2015 May; 6(3):280-8. PubMed ID: 25969712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National Cholesterol Educational Program and International Diabetes Federation diagnostic criteria for metabolic syndrome in an Italian cohort: results from the FIBAR Study.
    Mannucci E; Monami M; Bardini G; Ognibene A; Rotella CM
    J Endocrinol Invest; 2007 Dec; 30(11):925-30. PubMed ID: 18250613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative performance of three metabolic syndrome definitions in the prediction of acute coronary syndrome.
    Koutsovasilis A; Protopsaltis J; Triposkiadis F; Kokkoris S; Milionis HJ; Zairis MN; Skoularigis J; Koukoulis G; Korantzopoulos P; Melidonis A; Foussas SG
    Intern Med; 2009; 48(4):179-87. PubMed ID: 19218766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects--a population-based study comparing three different definitions.
    Nilsson PM; Engström G; Hedblad B
    Diabet Med; 2007 May; 24(5):464-72. PubMed ID: 17381496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.